BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 26, 2016
View Archived Issues
New collaboration to focus on GPCR targets for cancer immunotherapy
Read More
New mutations in known disease-associated genes
Read More
BERG enters CRADA with partners of DDCBCP
Read More
S-63845 is a highly potent and selective MCL1 inhibitor with efficacy in cancer models
Read More
Selective phosphorylation of Rb by p38 prevents proliferation in cancer cells
Read More
Alphamab starts phase I trial of KN-015
Read More
OneStep-1 and OneStep-2 phase III trials do not meet primary clinical endpoint
Read More
Nordic Nanovector and Heidelberg Pharma collaborate on ADCs for leukemia
Read More
Oasmia Pharmaceutical acquires Karo Pharma's KB-9520
Read More
Heat Biologics forms new subsidiary, Zolovax
Read More
[18F]PF-06684511 as a novel BACE-selective radioligand for PET imaging
Read More
Anacor Pharmaceuticals patents antiprotozoal agents
Read More
AstraZeneca reports promising findings from phase III SOLO-2 trial of Lynparza in ovarian cancer
Read More
Lewis and Clark Pharmaceuticals discloses A2B receptor antagonists
Read More
Active Biotech grants NeoTX exclusive rights to develop and commercialize Anyara for cancer
Read More
Horizon Pharma completes acquisition of Raptor Pharmaceutical
Read More
Auspex Pharmaceuticals describes S1P1 receptor modulators
Read More
Gilead Sciences develops HIV integrase inhibitors
Read More
Propanc Health Group completes toxicokinetic study of PRP
Read More
CureDuchenne announces launch of cTAP consortium
Read More
OncoGenex reports survival results from phase II trial of apatorsen in metastatic bladder cancer
Read More
Portola Pharmaceuticals submits NDA to FDA for betrixaban
Read More
FDA grants fast track designation to ABO-102 for MPS IIIA
Read More
AmpliPhi Biosciences reports topline results from phase I trial of AB-SA01
Read More
Fimbrion Therapeutics to collaborate with GSK to develop UTI-preventing drug
Read More
New variant in SERPINC1 may be a disease-causing mutation for antithrombin-III type I deficiency
Read More
Scynexis completes additional studies of SCY-078
Read More
Harvard College presents antibacterial agents
Read More